OOIR: Observatory of International Research

Papers

(The TQCC of Scandinavian Journal of Rheumatology is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Orbital and periorbital inflammation in VEXAS syndrome	22
Large-vessel giant cell arteritis after COVID-19 vaccine	19
Anti-Ro52/TRIM21 is independently associated with pulmonary arterial hypertension and mortality in a cohort of systemic sclerosis patients	16
Presenting features and outcomes of cranial-limited and large-vessel giant cell arteritis: a retrospective cohort study	15
Association between inflammasome-related polymorphisms and psoriatic arthritis	14
The validity of rheumatoid arthritis diagnoses in Finnish biobanks	14
Psoriatic arthritis, axial spondyloarthritis and rheumatoid arthritis in Norway: nationwide prevalence and use of biologic agents	13
Autoantibodies are major predictors of arthritis development in patients with anti-citrullinated protein antibodies and musculoskeletal pain	12
Systemic Capillary Leak Syndrome triggered by SARS-CoV2 infection: Case Report and Systematic Review	12
Incidence and prevalence of rheumatoid arthritis in Denmark from 1998 to 2018: a nationwide register-based study	11
Risk of cancer in patients with ankylosing spondylitis: a nationwide cohort study in Taiwan	10
Tocilizumab and rituximab for anti-MDA-5 positive amyopathic dermatomyositis complicated with macrophage activation syndrome and progressive fibrosing interstitial lung disease	10
Using a novel smartphone application for capturing of patient-reported outcome measures among patients with inflammatory arthritis:A randomized, crossover, agreement study	9
Feasibility and estimated efficacy of blood flow restricted training in female patients with rheumatoid arthritis: a randomized controlled pilot study	9
Pregnancy outcome in women with different rheumatic diseases: a retrospective analysis	9
The changing incidence of rheumatoid arthritis over time in north-west Greece: data from a referral centre	9
Interval prolongation of etanercept in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a randomized controlled trial	9
Tapering of Etanercept is feasible in patients with Rheumatoid Arthritis in sustained remission: a pragmatic randomized controlled trial	9
Rheumatoid arthritis and the risk of major cardiometabolic diseases: a Mendelian randomization study	9
Validity of clinical psoriatic arthritis diagnoses made by rheumatologists in the Swedish National Patient Register	9
Serum levels of n-3 and n-6 polyunsaturated fatty acids in patients with systemic lupus erythematosus and their association with disease activity: a pilot study	9
Adenosine receptor A2a blockade by caffeine increases IFN–gamma production in Th1 cells from patients with rheumatoid arthritis	8
Complications after minor salivary gland biopsy: a retrospective study of 630 patients from two Swedish centres	8
Validation and characterization of venous thromboembolism diagnoses in the Swedish National Patient Register among patients with rheumatoid arthritis	8
Rheumatological evaluation of patients with interstitial lung disease	8

Increased synovial galectin-3 induce inflammatory fibroblast activation and osteoclastogenesis in patients with rheumatoid arthritis	8
Early radiological progression remains associated with long-term joint damage in real-world rheumatoid arthritis patients treated to the target of remission	8
Temperature response to cold challenge and mobile phone thermography as outcome measures for systemic sclerosis-related Raynaud’s phenomenon	8
Self-limiting reactive disease mimicking polymyalgia rheumatica following Moderna COVID-19 vaccine	8
Twenty-year changes in mortality rates and underlying causes of death in patients with rheumatoid arthritis-associated interstitial lung disease	8
Clinical phenotypes of Behçet’s syndrome in a large cohort of Italian patients: focus on gender differences	8
Reduction of Pneumocystis jirovecii pneumonia and bloodstream infections by trimethoprim–sulfamethoxazole prophylaxis in patients with rheumatic diseases	8
Pentraxin-3 – a potential biomarker in ANCA-associated vasculitis	8
Extended-release tofacitinib improves refractory Takayasu’s arteritis	8
Relationship between sex and clinical and imaging features of early axial spondyloarthritis: results from a 48 month follow-up (Italian arm of the SPondyloArthritis Caught Early (SPACE) study)	7
Lifestyle factors and comorbidities in gout patients compared to the general population in Western Sweden: results from a questionnaire study	7
Diffuse idiopathic skeletal hyperostosis in elderly Icelanders and its association with the metabolic syndrome: the AGES-Reykjavik Study	7
Cost-effectiveness of a telehealth intervention in rheumatoid arthritis: economic evaluation of the Telehealth in RA (TeRA) randomized controlled trial	7
Disease activity in women with ankylosing spondylitis remains higher under Tumour Necrosis Factor inhibitor treatment than in men: a five-year observational study	7
Detection of human cytomegalovirus in synovial neutrophils obtained from patients with rheumatoid arthritis	7
Pretreatment resistin levels are associated with erosive disease in early rheumatoid arthritis treated with disease-modifying anti-rheumatic drugs and infliximab	7
Role of comorbidities on therapeutic persistence of biological agents in rheumatoid arthritis: results from the RECord-linkage On Rheumatic Disease study on administrative healthcare databases	6
Worse scores but similar patterns of disease activity: interpreting outcomes in women with axial spondyloarthropathy	6
The feasible maintenance dose of corticosteroid in Takayasu arteritis in the era of biologic therapy	6
Differential diagnostics of polymyalgia rheumatica in a university hospital in Finland	6
Prognostic value of peripheral blood markers in patients with myositis-associated interstitial lung diseases	6
Diagnosing axial spondyloarthritis by multidiciplinary team conference at 3.5 years’ follow-up in a cohort of patients with disease features according to the ASAS criteria	6
Complement activation prior to symptom onset in myeloperoxidase ANCA-associated vasculitis but not proteinase 3 ANCA associated vasculitis - A Swedish biobank study	6
Widespread non-joint pain in early rheumatoid arthritis	6
Prostanoids in scleroderma microangiopathy: clinical and pharmacoeconomic comparison between two intravenous regimens	6
Muscle wasting, a neglected complication associated with physical dysfunction in elderly patients with rheumatoid arthritis: a cross-sectional observational study	6
Efficacy and safety of plasma exchange in interstitial lung diseases with anti-melanoma differentiation-associated 5 gene antibody positive clinically amyopathic dermatomyositis	6
Increased prevalence of sleep disturbance in psoriatic arthritis is associated with inflammatory and non-inflammatory measures	6
Major reduction of ultrasound-detected synovitis during subcutaneous tocilizumab treatment: results from a multicentre 24 week study of patients with rheumatoid arthritis	6
Serum golimumab concentration and anti-drug antibodies are associated with treatment response and drug survival in patients with inflammatory joint diseases: data from the NOR-DMARD study	6
Can pain flares in knee osteoarthritis be predicted?	5
Prevalence of survey-based criteria for fibromyalgia and impact on hospital burden: a 7 year follow-up study from an outpatient clinic	5
Associations of serum monocyte-to-high-density lipoprotein cholesterol ratio with digital ulcers and skin fibrosis in patients with systemic sclerosis	5
The Symptoms in Persons At Risk of Rheumatoid Arthritis (SPARRA) questionnaire: predicting clinical arthritis development	5
Impact of osteoarthritis disease severity on treatment patterns and healthcare resource use: analysis of real-world data	5
Patient characteristics in Behçet’s Syndrome and their associations with major organ involvement: a single-centre experience of 2118 cases	5
Rheumatoid cachexia in early rheumatoid arthritis: prevalence and associated variables	5
Behcet’s-like disease in a patient treated with Ixekizumab for chronic plaque psoriasis	5
Anti-synthetase syndrome occurring after SARS-CoV-2 infection	5
The impact of a structured one–day seminar on disease–specific knowledge, lifestyle habits and disease impairment in ANCA–associated vasculitis. Results of a randomized, controlled study	5
Prevalence of joint, entheseal, tendon, and bursal findings in young, healthy individuals by musculoskeletal ultrasound	5
Pain extent is associated with Central Sensitization Inventory but not widespread pressure pain sensitivity or psychological variables in women with fibromyalgia	5
Resilience of systemic sclerosis patients following the first COVID-19 wave in Italy	5
Renal and overall outcomes of double-positive (ANCA and anti-GBM antibodies) patients compared to ANCA-associated vasculitis patients with severe renal involvement: A multicenter retrospective study w	5
Risk of Staphylococcus aureus bacteraemia in patients with rheumatoid arthritis and the effect of orthopaedic implants on the risk: a nationwide observational cohort study	5
Gout in Dalarna, Sweden – a population-based study of gout occurrence and compliance to treatment guidelines	5
Serum CCL28 as a biomarker for diagnosis and evaluation of Sjögren’s syndrome	4
Validity and reliability of the Swedish version of the Self-Efficacy for Managing Chronic Disease scale for individuals with systemic sclerosis	4
Myocarditis as a manifestation of Erdheim–Chester Disease: successful use of anti- IL1 and BRAF inhibitor combination therapy	4
Comparison of outcomes using the rituximab originator MabThera with the biosimilar Truxima in patients with ANCA-associated vasculitis	4

Evaluation of risk factors and biomarkers related to arterial and venous thrombotic events in idiopathic inflammatory myopathies	4
Transition to adult care in Finnish adolescents with juvenile idiopathic arthritis	4
Refractory mixed proliferative and membranous lupus nephritis treated with the topoisomerase I inhibitor irinotecan as add-on therapy	4
Favorable clinical response and drug retention of anti-IL-6 receptor inhibitor in rheumatoid arthritis with high CRP levels: the ANSWER cohort study	4
Smoking associated with reduced odds of Sjögren’s syndrome among rheumatoid arthritis patients	4
Greater trochanteric pain syndrome: predicting who will respond to a local glucocorticoid injection	4
Early infectious risk in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis according to remission-induction therapy	4
Discrepancy between clinical and ultrasound remissions in rheumatoid arthritis: a multicentre ultrasound cohort study in Japan	4
A study on echocardiographic findings in hospitalized patients with connective tissue diseases	4
Disease activity-guided tapering of biologics in patients with inflammatory arthritis: a pragmatic, randomized, open-label, equivalence trial	4
Trends in the occurrence of ischaemic heart disease over time in rheumatoid arthritis: 1821 patients from 1972 to 2017	4
Cluster analysis identifies unmet healthcare needs among patients with rheumatoid arthritis	4
How good is the agreement between clinical diagnoses and classification criteria fulfilment in axial spondyloarthritis? Results from the SPARTAKUS cohort	4
Increased risk of end-stage renal disease in patients with systemic sclerosis	4
Construct validity of Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and Ankylosing Spondylitis Disease Activity Score (ASDAS) treatment target cut-offs in a BASDAI treat-to-target axial	4
Heterogenous bone response to biologic DMARD therapies in rheumatoid arthritis patients and their relationship to functional indices	4
Corticosteroids reduce vascular ultrasound sensitivity in fast- track pathways (FTP): results from Coventry Multi-Disciplinary FTP for cranial Giant Cell Arteritis	4